Di Nuzzo Private Wealth, Inc. Biomarin Pharmaceutical Inc Transaction History
Di Nuzzo Private Wealth, Inc.
- $617 Million
- Q1 2025
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 24 shares of BMRN stock, worth $1,349. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24
Previous 13
84.62%
Holding current value
$1,349
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BMRN
# of Institutions
668Shares Held
184MCall Options Held
1.24MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.28 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.07 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$1 Billion1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$841 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$607 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.5B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...